DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C4083212 | Alopecia, Male Pattern | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C0001973 | Alcoholic Intoxication, Chronic | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C2937421 | Prostatic Hyperplasia | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C0030319 | Panic Disorder | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C1269683 | Major Depressive Disorder | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C0017638 | Glioma | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C0008043 | Chiari-Frommel Syndrome | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C0003469 | Anxiety Disorders | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C0011570 | Mental Depression | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C0268398 | Familial lichen amyloidosis | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C0006826 | Malignant Neoplasms | SRD5A1 | 6715 | steroid 5 alpha-reductase 1 | P18405 |
C0027651 | Neoplasms | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C2676272 | Alopecia, Androgenetic, 3 | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0033578 | Prostatic Neoplasms | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0001973 | Alcoholic Intoxication, Chronic | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C2931456 | Prostate cancer, familial | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C2930619 | Sex Differentiation Disorders | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0376358 | Malignant neoplasm of prostate | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0600139 | Prostate carcinoma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0848558 | Hypospadias | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0041408 | Turner Syndrome | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C2239176 | Liver carcinoma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C1704272 | Benign Prostatic Hyperplasia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0678222 | Breast Carcinoma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C1140680 | Malignant neoplasm of ovary | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024